Adenocarcinoma of the urachus associated with elevated levels of CA 125

Journal of Urology

Volumn 145, Issue 1, 1991, Pages 140-141

  Guarnaccia, S ^a   Pais, V ^a   Grous, J ^a   Spirito, N ^a  

^a ST ELIZABETH'S MEDICAL CENTER   (United States)

Author keywords

adenocarcinoma; antigens; bladder neoplasms; carcinoma; tumor associated, carbohydrate; urachus

Indexed keywords

CA 125 ANTIGEN; CISPLATIN; DOXORUBICIN; FLUOROURACIL; MITOMYCIN C; TUMOR MARKER;

AGED; ARTICLE; BLADDER CARCINOMA; CASE REPORT; CYSTECTOMY; FEMALE; HUMAN; PRIORITY JOURNAL;

EID: 0026011077     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(17)38271-X     Document Type: Article

References (8)

1. C.A. Sheldon R.V. Clayman R. Gonzalez R.D. Williams E.E. Fraley Malignant urachal lesions J. Urol. 131 1984 1
2. E.D. Whitehead A.N. Tessler Carcinoma of the urachus Brit. J. Urol. 43 1971 468
3. P.M. Quilty Urachal carcinoma: a response to chemotherapy Brit. J. Urol. 60 1987 372
4. G.E. Schubert M.B. Pavkovic B.A. Bethke-Bedürftig Tubular urachal remnants in adult bladders J. Urol. 127 1982 40
5. F.K. Mostofi R.V. Thomason A.L. Dean Mucous adeno carcinoma of the urinary bladder Cancer 8 1955 741
6. R.C. Bast Jr. T.L. Klug E. St. John E. Jenison J.M. Niloff H. Lazarus R.S. Berkowitz T. Leavitt C.T. Griffiths L. Parker V.R. Zurawski Jr. R.C. Knapp A radio-immunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer New Engl. J. Med. 309 1983 883
7. M.E. van der Burg F.B. Lammes W.L. van Putten G. Stoter Ovarian cancer: the prognostic value of the serum half-life of CA125 during induction chemotherapy Gynec. Oncol. 30 1988 307
8. C. Haglund Tumour marker antigen CA125 in pancreatic cancer: a comparison with CA19-9 and CEA Brit. J. Cancer 54 1986 897